Finacea 01
Finacea Foam Aerosol, Foam
Product Images NDC 50222-303
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Finacea Foam (NDC 50222-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leo Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Finacea 02
This appears to be a description of a topical foam product called Finacea, containing 15% azelaic acid as the active ingredient. The product is manufactured by "LD Pramma e" and is for topical use only. It is not to be used for ophthalmic, oral, or infravaginal use. The foam is recommended to be used twice daily on the cheeks, forehead, and nose area and is stored at room temperature. The package should be read for further instructions and the product should be discarded within eight weeks after opening. There are also warnings and precautions regarding the use of this product, including the risk of fire, smoking, and exposure to heat.*
Finacea 03
Finacea Foam is a topical medication used for facial acne treatment. It should be applied twice daily, in the morning and evening, to the entire facial area. It comes in a pressurized aluminum can and contains 16% azelaic acid, as well as additional inactive ingredients. The product should be stored at a controlled room temperature and discarded 8 weeks after opening. The medication is not to be used for ophthalmic, oral or intravaginal use. This package insert provides limited information about the product's usage and directions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
